NDC 63323-482-01 - Xylocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-482
- Requested NDC
- 63323-482-01
- Package NDCs from labels
- 63323-482-41, 63323-482-26, 63323-482-01, 63323-482-17, 63323-482-03, 63323-482-27, 63323-482-05, 63323-482-57
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2026-11-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xylocaine 1% (Lidocaine HCL and Epinephrine 1:100,000) USP | Henry Schein, Inc. | 2026-11-13 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-08-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - Sportpharm LLC | Sportpharm LLC | 2026-03-21 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - ProPharma Distribution | ProPharma Distribution | 2025-07-18 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
| XYLOCAINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-05-29 | HUMAN PRESCRIPTION DRUG LABEL |
| Leep RediKit | CooperSurgical, Inc. | 2023-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| LIDOCAINE HCl AND EPI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2022-07-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - Cardinal Health | Cardinal Health | 2020-06-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Cardinal Health | Cardinal Health | 2019-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
| QKit | CooperSurgical, Inc. | 2016-08-16 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine | Physicians Total Care, Inc. | 2012-02-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-482-01 | Xylocaine | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 10 | 13 | |
| 63323-482-03 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-482-05 | Xylocaine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 13 | |
| 63323-482-17 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-482-27 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-482-57 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-482-26 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-482-41 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-482 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 6 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
| 63323-482 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250515_4dd52202-8eef-4136-92dd-ada573b7cf74.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-482-01 | ML - Milliliter | 63323-482 | c7c960aa-c042-4c76-8985-abfc7ddffd35 | 1 | 2019-11-12 |
| 63323-482-03 | ML - Milliliter | 63323-482 | 683318c9-c032-429d-b0a6-5acf426a0cff | 1 | 2019-11-12 |
| 63323-482-05 | ML - Milliliter | 63323-482 | 8e4a4ff6-bc30-4291-b650-70cbca55a0ea | 1 | 2019-11-12 |
| 63323-482-10 | ML - Milliliter | 63323-482 | eeb605c4-0d24-4bcc-812b-c9af4171f021 | 1 | 2013-02-11 |
| 63323-482-17 | ML - Milliliter | 63323-482 | 174b5879-d07f-4342-8e60-68c6453f1219 | 1 | 2012-07-24 |
| 63323-482-26 | ML - Milliliter | 63323-482 | e06d4a2e-b1ab-406d-9e85-1d9d66f47f9e | 1 | 2016-06-14 |
| 63323-482-27 | ML - Milliliter | 63323-482 | 8b11b61e-7a9a-4afd-9877-cf93a6041364 | 1 | 2012-07-24 |
| 63323-482-57 | ML - Milliliter | 63323-482 | 0efa69ac-a284-4b6c-86e8-d723284f92e2 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | b8803e38-fe30-48ec-9399-013f2880e0eb | 2020-04-09 | Warnings, Adverse reactions | 1737566 V13007Z41A |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a2b8220f-e33a-51c3-e053-2995a90a0734 | 2020-04-07 | Warnings, Adverse reactions | 451W47IQ8X |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a2bba76a-08ce-6902-e053-2995a90ab9c9 | 2020-04-07 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose and Electrolyte No. 48 | SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, MONOBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE AND DEXTROSE MONOHYDRATE | Baxter Healthcare Company | b283a454-0c20-4fbf-92d3-dae1f3cd3cad | 2020-02-13 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | fbc01464-8885-4075-af41-911ffec5ae92 | 2020-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | Baxter Healthcare Company | 8bcf5572-49e1-4302-9522-56f57904cb4a | 2019-12-29 | Warnings, Adverse reactions | 059QF0KO0R |
| bcdd30cb-356b-4761-b42d-5a03325f308a | 95f92518-2250-473d-9707-87b61fdff9f1 | 2019-09-09 | Warnings, Adverse reactions | bcdd30cb-356b-4761-b42d-5a03325f308a 95f92518-2250-473d-9707-87b61fdff9f1 | ||
| Plasma-Lyte A | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Baxter Healthcare Corporation | 6ec9e61c-2c26-402f-8604-f446b2e34058 | 2019-08-05 | Warnings, Adverse reactions | 451W47IQ8X |
| CPAP Mask cleaning wipes | BENZETHONIUM CHLORIDE AND BENZALKONIUM CHLORIDE | JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD. | 412e6fec-5af5-45f7-8c6b-393b884e161c | 2019-06-07 | Warnings | F5UM2KM3W7 |
| BZK Towelette | BENZALKONIUM CHLORIDE | Acme United Corporation | 866fdc1e-19b2-4d79-e053-2a91aa0a36fe | 2019-04-16 | Warnings | F5UM2KM3W7 |
| Callington Anti-Bacterial Hand Sanitiser | BENZALKONIUM CHLORIDE | JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD. | 1c6650c9-29fa-4fba-8442-fe294a2087c0 | 2019-02-25 | Warnings | F5UM2KM3W7 |
| Potassium Chloride in Dextrose and Sodium Chloride | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Baxter Healthcare Company | c553fed1-3de5-4826-8eff-633b5923bf0b | 2019-02-21 | Warnings, Adverse reactions | 451W47IQ8X |
| DermacinRx Lidotral | LIDOCAINE HYDROCHLORIDE | PureTek Corporation | 23efec58-67cc-418d-85f5-7ef156443cbf | 2019-02-04 | Warnings, Adverse reactions | V13007Z41A |
| Potassium Chloride in Sodium Chloride | POTASSIUM CHLORIDE AND SODIUM CHLORIDE | Baxter Healthcare Company | becc7410-0a25-49f5-b0c3-240078479dc8 | 2019-01-11 | Warnings, Adverse reactions | 451W47IQ8X |
| Skin Klear Acne Relief | TRIBASIC CALCIUM PHOSPHATE, FUMARIA OFFICINALIS FLOWERING TOP, ARCTIUM LAPPA ROOT, SODIUM CHLORIDE, SAPONARIA OFFICINALIS ROOT, SILICON DIOXIDE, SOLIDAGO VIRGAUREA FLOWERING TOP, SULFUR, VIOLA TRICOLOR | Homeocare Laboratories | 65afbc20-611b-4bc4-a151-c633bec66a82 | 2018-12-31 | Warnings | 451W47IQ8X |
| Gastrozen | COFFEA TOSTA, GLYCYRRHIZA, PHYTOLACCA, TARAXACUM, HYDRASTIS, ARSENICUM ALB, GELSEMIUM, MERC SOLUB, NITRICUM AC, NUX VOM, PETROLEUM, PHOSPHORICUM AC, PHOSPHORUS, BROMIUM, CADMIUM SULPHURICUM, CINCHONA, CONIUM, HYDROGEN, IODIUM, LACHESIS, PULSATILLA, SILICEA, SULPHURICUM AC | Natural Creations, Inc | 98dd756f-6774-47c3-bdfb-deff82fb801d | 2018-12-21 | Warnings | 9679TC07X4 |
| H.M.D. | ALLIUM SAT, AVENA, BERBER VULG, LAPPA, PHYTOLACCA, SOLIDAGO, ALUMINA, ARG NIT, BARYTA CARB, BERYLLIUM, CADMIUM MET, CURPRUM MET, FLUORICUM ACIDUM, INDIUM, IODIUM, LITHIUM CARB, MERC SOLUB, NICCOLUM CARB, NITROGENUM OXYGENATUM, PLUMB MET, SELENIUM, STRONTIUM CARB, TITANIUM, ARSENICUM ALB, NAT MUR, NUX VOM | Zorex International | 8c53091a-904d-4756-93e4-17143c5b48e9 | 2018-12-21 | Warnings | 9679TC07X4 451W47IQ8X |
| Imucode | ASTRAGALUS, HYDRASTIS, ADRENALINUM, THYROIDINUM, PITUITARUM POSTERIUM, ARSENICUM ALB, BAPTISIA, BARYTA CARB, BARYTA MUR, BROMIUM, CANDIDA ALB, CEANOTHUS, CHININUM SULPH, CONIUM, HEPAR SULPH CALC, IGNATIA, INDIUM, IODIUM, MERC SOLUB, PHYTOLACCA, SULPHUR | Natural Creations, Inc | be30901c-0673-4af0-8128-83ed59ff04b1 | 2018-12-21 | Warnings | 9679TC07X4 |
| GUNA-ALLERGY-PREV | AMBROSIA ARTEMISIIFOLIA - ANGUILLA ROSTRATA BLOOD SERUM - ARUNDO PLINIANA ROOT - BLACK CURRANT - CHELIDONIUM MAJUS - CITRIC ACID MONOHYDRATE - HISTAMINE DIHYDROCHLORIDE - HUMAN INTERLEUKIN 12 - INTERFERON GAMMA-1B - MANGANESE GLUCONATE - PARIETARIA OFFICINALIS - PHLEUM PRATENSE - SODIUM PYRUVATE - SODIUM SULFATE - SUCCINIC ACID - SULFUR - URTICA URENS - VIBURNUM OPULUS ROOT - WYETHIA HELENIOIDES ROOT - | Guna spa | adae93c0-1de9-4e45-ab58-148171f0dc86 | 2018-12-21 | Warnings | 2968PHW8QP |
| Vitality Female | ARALIA QUINQUEFOLIA, AVENA SATIVA, BERBERIS VULGARIS, CAUSTICUM, GRAPHITES, LACHESIS MUTUS, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SEPIA | Natural Creations, Inc | 679ba86d-bf84-4ded-b0bf-d55a0df9faa4 | 2018-12-21 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.